BOC Sciences not only provided efficient synthesis but also detailed stability and cleavage reports, greatly accelerating our project timeline." Mr
Urva S, Coskun T, Loh MT et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicenter, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Energy-boosting shots like B12 and Lipo B may provide an immediate lift, while others, like Biotin, may take longer to show noticeable results
The limitless future of RNA therapeutics
Cognitive and Neuroprotective Effects Research: In rodent models of oxidative stress, excitotoxicity (kainic acid), and hypoxia, DSIP protected hippocampal neurons, reduced lipid peroxidation, normalized GABA/serotonin receptor binding, and improved memory consolidation during post-training sleep periods